EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

FBXO22-mediated ubiquitination of KLF10 promoting pancreatic cancer proliferation and invasion

Xiaorong Liu, Xuesong He, Yuanmin Hu, Yuzhe Xue, Fenfen Jiang, Xiaoguang Wang

Pancreatology · 2026

DOI: 10.1016/j.pan.2025.11.016 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pancreatology, 2026. Verfasst von Xiaorong Liu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary Surgery, The Second Affiliated Hospital of Jiaxing University, Jiaxing, China. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, F-Box Proteins, Kruppel-Like Transcription Factors, Early Growth Response Transcription Factors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Science and Technology Project of Zhejiang Province, Zhejiang Province Natural Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Pancreatic cancer (PC) is a highly aggressive cancer with poor clinical outcomes. F-box only protein 22 (FBXO22), as an integral part of the SCF E3 ubiquitin ligase complex, has been associated with various cancers, but its role in PC remains underexplored. METHODS: FBXO22 expression in pancreatic cancer tissues and adjacent normal tissues was analyzed by bioinformatics and validated using quantitative real-time PCR (qPCR). Functional assays, including proliferation, invasion, and apoptosis analyses, were conducted in pancreatic cancer cell lines following FBXO22 overexpression or knockdown. Mass spectrometry-based proteomic profiling was performed to identify potential ubiquitination targets of FBXO22. The interaction between FBXO22 and candidate targets was confirmed by co-immunoprecipitation, western blotting, and ubiquitination assays. The in vivo role of FBXO22 in pancreatic tumor progression was further evaluated using a xenograft model in BALB/c nude mice. RESULTS: FBXO22 was significantly overexpressed in pancreatic cancer tissues compared to adjacent normal tissues. FBXO22 overexpression enhanced pancreatic cancer cell proliferation and invasion, whereas its knockdown suppressed these oncogenic properties. Mass spectrometry identified KLF10 as a potential substrate of FBXO22-mediated ubiquitination. Further experiments confirmed that FBXO22 promotes KLF10 degradation via the ubiquitin-proteasome pathway. Overexpression of KLF10 suppressed pancreatic cancer cell proliferation and induced apoptosis through the TGF-β signaling pathway. In vivo, FBXO22 knockdown significantly inhibited pancreatic tumor growth and increased KLF10 expression. CONCLUSION: FBXO22 promotes pancreatic cancer progression by mediating KLF10 ubiquitination and degradation, thereby impairing its tumor-suppressive functions. FBXO22 may serve as a potential oncogenic and therapeutic target associated with pancreatic cancer progression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic NeoplasmsF-Box ProteinsKruppel-Like Transcription FactorsEarly Growth Response Transcription FactorsHumansCell ProliferationAnimalsUbiquitinationMiceMice, NudeCell Line, TumorMice, Inbred BALB CNeoplasm InvasivenessGene Expression Regulation, NeoplasticMaleApoptosisFemaleReceptors, Cytoplasmic and Nuclear

Stichwörter der Autor:innen

FBXO22KLF10Pancreatic cancerUbiquitination

Substanzen

F-Box ProteinsKruppel-Like Transcription FactorsFBXO22 protein, humanEarly Growth Response Transcription FactorsReceptors, Cytoplasmic and Nuclear

Autor:innen und Institutionen

  • Department of Hepatobiliary Surgery, The Second Affiliated Hospital of Jiaxing University, Jiaxing, China.
  • Intensive Care Unit (ICU), The Second Affiliated Hospital of Jiaxing University, China.
  • Zhejiang Chinese Medical University, China.
  • Department of Geriatrics, The Second Affiliated Hospital of Jiaxing University, China. Electronic address: jiangfenfen06@163.com.
  • Department of Hepatobiliary Surgery, The Second Affiliated Hospital of Jiaxing University, Jiaxing, China. Electronic address: xiaoguangwangs@163.com.

Förderung

  • Medical Science and Technology Project of Zhejiang Province
  • Zhejiang Province Natural Science Foundation

Zitieren

APA

Liu, X., He, X., Hu, Y., Xue, Y., Jiang, F., & Wang, X. (2026). FBXO22-mediated ubiquitination of KLF10 promoting pancreatic cancer proliferation and invasion. Pancreatology. https://doi.org/10.1016/j.pan.2025.11.016

Vancouver

Liu X, He X, Hu Y, Xue Y, Jiang F, Wang X. FBXO22-mediated ubiquitination of KLF10 promoting pancreatic cancer proliferation and invasion. Pancreatology. 2026. doi:10.1016/j.pan.2025.11.016

BibTeX
@article{Liu2026,
  author = {Liu, Xiaorong and He, Xuesong and Hu, Yuanmin and Xue, Yuzhe and Jiang, Fenfen and Wang, Xiaoguang},
  title = {FBXO22-mediated ubiquitination of KLF10 promoting pancreatic cancer proliferation and invasion},
  journal = {Pancreatology},
  year = {2026},
  doi = {10.1016/j.pan.2025.11.016}
}
Kostenlos starten →